Mixing insulin analogs for Type 1 kids is safe, say researchers
|
We’re usually told it’s a big health and safety no-no to mix ‘n’ match medications, right? Well, here’s an exception that affects diabetics. Apparently, youngsters with Type 1 diabetes and their parents/caregivers can safely mix rapid-acting and long-acting insulin analogs in the same syringe. The results of a new study published in the Journal of Pediatrics (April 2006) show that doing so does not compromise blood sugar stability in the long-term.
Examples of rapid-acting insulin analogues are Apridra and NovoRapid. Lantus is an examples of a long-acting insulin glargine. For some kids, mixing the two together could potentially reduce the number of insulin shots required daily. This is always good news for children and their parents.
Print Version
Tell-a-Friend comments powered by Disqus